New range of StarBright™ Dyes developed specifically for spectral flow cytometry provide greater flexibility in immunology research
CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
The MosaiQ instrument is a next-generation, continuous random-access immunoassay platform offering labs automation, simple workflows, fast, multiplexed results and actionable insights for complex-to-diagnose conditions
With its unique combination of low-cost and high accuracy, ppmSeq marks a real breakthrough in sequencing technology
Compact, high-sensitivity solution for accurate macromolecule analysis
Oncomine Dx Target Test approved to identify patients eligible for HERNEXEOS (zongertinib tablets), the first and only orally administered targeted treatment for HER2 (ERBB2)-mutant NSCLC
Enabling accurate and accessible ethyl alcohol testing across moderate complexity laboratories
Initiative to expand testing access to underserved U.S. communities
The launch marks the highlight of a 10-year journey
Researchers receive funding to explore how fluorescent materials can detect the presence of pesticides and herbicides in food production
AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease
Direct, high-resolution imaging of cells on membrane inserts without removal or disruption
Enhance sample traceability, streamline inventory, and support compliance with a trusted, user-friendly LIMS solution
From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing
The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept
New solution delivers high-integrity DNA exceeding 100 kb in under two hours, supporting automation across KingFisher platforms to accelerate long-read sequencing research
To help simulate exact environmental conditions for shipping, storage, or research environments, offering repeatable and consistent performance
Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research
Multicenter study shows IntelliSep enables an increase in safe ED discharges, easing inpatient bed shortages without increasing 30-day return visits
The test operates using the company’s fully automated Lumipulse G1200 instrument system
Smarter packaging designed with customer needs in mind
The comprehensive portfolio advances laboratory processes through the ability to provide earlier and more efficient detection and diagnosis
